Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.
about
Hereditary chronic pancreatitisPatterns of GI disease in adulthood associated with mutations in the CFTR geneMolecular dynamics simulations reveal structural instability of human trypsin inhibitor upon D50E and Y54H mutations.Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders.Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.Meandering main pancreatic duct as a relevant factor to the onset of idiopathic recurrent acute pancreatitis.Review of idiopathic pancreatitisAcute pancreatitis due to a duodenal ulcer.Evaluating Adults With Idiopathic Pancreatitis for Genetic Predisposition: Higher Prevalence of Abnormal Results With Use of Complete Gene Sequencing.Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis.Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis.Functional characteristics of L1156F-CFTR associated with alcoholic chronic pancreatitis in Japanese.Clan genomics and the complex architecture of human disease.Chronic pancreatitis--definition, etiology, investigation and treatment.Ansa pancreatica as a predisposing factor for recurrent acute pancreatitis.CFTR: A New Horizon in the Pathomechanism and Treatment of Pancreatitis.Environmental risk factors for chronic pancreatitis and pancreatic cancer.Total pancreatectomy for recurrent acute and chronic pancreatitis: a critical review of patient selection criteria.An Evaluation of Factors Associated With Pathogenic PRSS1, SPINK1, CTFR, and/or CTRC Genetic Variants in Patients With Idiopathic Pancreatitis.Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation.Human pancreatitis and the role of cathepsin B.Cathepsin B gene polymorphism Val26 is not associated with idiopathic chronic pancreatitis in European patientsGenetic, epidemiological, and clinical aspects of hereditary pancreatitis: a population-based cohort study in Denmark.Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts
P2860
Q21203019-C831ACFD-FAFB-4EC5-BB0E-8EF080188285Q24673570-F7BAD323-C017-4132-B141-51DDF7F91319Q30421015-2B20C8C8-7CFB-48F4-9EE7-A04171E2A933Q33596314-B78FD378-7195-4814-8B6C-46BEFD263663Q33608581-6623FAE1-1F42-4807-95F3-E5EE30B13E7CQ34093790-6AEB9594-B760-4E24-BD2B-A0F483875789Q34118468-25A4398F-E3C9-4F4C-9809-71C0B069EEDDQ34289027-71539743-92A3-4F40-8211-B288A4F700F2Q34382873-DF8F776E-670E-4B92-A435-B2C500E48CB5Q34658738-1E04ED68-4728-4C47-B63D-42C00EE62911Q34674594-0BB5171D-A5AD-4BBE-BF25-7D7B5B54396AQ35159183-307BD7F0-09AE-46E7-8599-A4C8AF04B96DQ35209665-D35A710B-2FC2-4811-9C4D-98941AC681A1Q35958547-5A55C9D1-7751-4BDA-998E-E3F917A09FBDQ36851578-1D1E5E29-40D1-4584-9C3D-60879C1D724AQ36974615-67072032-B0FE-4F75-81DF-E5EEFE024182Q37373270-9E5FD664-DBB5-409C-9613-6CEB786E4FBDQ37583400-B99DC4F5-38EF-4416-8508-496ABE071F5CQ37898422-AB16A0F4-A54E-4D8D-AF7E-F74EBB0533F9Q38658663-66D397E7-8758-49C8-9124-CCABA867D3A5Q39260953-22233C92-6CF4-4B76-9425-EE75A2A7B4F3Q41110653-D3B0F5CA-652D-4DCE-9FA1-F24A102423ACQ41819239-103728AD-C99E-4845-A789-1549E0112D50Q42410004-E68418BA-8DD0-4CDA-9AEF-71954467961CQ43054407-49C05188-1723-444F-9503-7A9EE488F71AQ46852919-C95B0863-9D6B-4381-BBC6-281E6428E6F8Q57165768-D5DA3F9F-1588-421B-8473-ED139FED2ADE
P2860
Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Complete cystic fibrosis trans ...... nic pancreatitis and controls.
@ast
Complete cystic fibrosis trans ...... nic pancreatitis and controls.
@en
type
label
Complete cystic fibrosis trans ...... nic pancreatitis and controls.
@ast
Complete cystic fibrosis trans ...... nic pancreatitis and controls.
@en
prefLabel
Complete cystic fibrosis trans ...... nic pancreatitis and controls.
@ast
Complete cystic fibrosis trans ...... nic pancreatitis and controls.
@en
P2093
P2860
P356
P1433
P1476
Complete cystic fibrosis trans ...... nic pancreatitis and controls.
@en
P2093
Bogdanova N
Dworniczak B
P2860
P304
P356
10.1136/GUT.2005.064808
P407
P577
2005-06-29T00:00:00Z